首页> 外国专利> METHOD OF EVALUATION OF CLINICAL EFFECTIVENESS OF INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME IN PATIENTS WITH DILATATION CARDIOMYOPATHY AND CIRCULATION DEFICIENCY OF IIA AND IIB DEGREE WITHOUT ASSOCIATED DISEASES AND THE PARENT HYPOTENSIVE RESPONSES

METHOD OF EVALUATION OF CLINICAL EFFECTIVENESS OF INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME IN PATIENTS WITH DILATATION CARDIOMYOPATHY AND CIRCULATION DEFICIENCY OF IIA AND IIB DEGREE WITHOUT ASSOCIATED DISEASES AND THE PARENT HYPOTENSIVE RESPONSES

机译：在没有伴发疾病和父母低血压反应的IIA和IIB度差的扩张性心肌病和循环障碍的患者中评估血管紧张素转化酶抑制剂的临床疗效的方法

页面导航

摘要
著录项
相似文献

摘要

FIELD: medicine, cardiology. SUBSTANCE: method involves assay of serum blood circulating immune complex level before and after two weeks course of treatment with mean therapeutic doses of inhibitor of angiotensin-converting enzyme. Change percent of indicated index is calculated after two weeks treatment course. Clinical effectiveness of inhibitor of angiotensin-converting enzyme is considered to be expressed if the level of circulating immune complexes is decreased by above 30% as compared with the parent one. Method ensures to evaluate effectiveness of treatment with inhibitors of angiotensin-converting enzyme without veloergometric testing. EFFECT: enhanced effectiveness of method. 2 tbl

机译：领域：医学，心脏病学。实质：该方法涉及用平均治疗剂量的血管紧张素转化酶抑制剂治疗前后两周疗程，测定血清血液循环免疫复合物水平。两周疗程后计算指示指标的变化百分比。如果循环免疫复合物的水平比亲本降低了30％以上，则认为可以表达血管紧张素转化酶抑制剂的临床有效性。该方法可确保评估血管紧张素转化酶抑制剂的治疗效果，而无需进行测压测试。效果：增强了方法的有效性。 2汤匙

著录项

公开/公告号RU2115123C1

专利类型
公开/公告日1998-07-10

原文格式PDF
申请/专利权人 IOLOGII IM. AKAD. N.D.STRAZHESKO MINISTERSTVA ZDRAVOOKHRANENIJA UKRAINY;
展开▼

申请/专利号RU19940030047
发明设计人 DUBROVSKAJA GALINA VLADIMIROVNA;VORONKOV LEONID GEORGIEVICH;KORNILINA ELENA MIKHAJLOVNA;RJABENKO DMITRIJ VASILEVICH;
展开▼

申请日1994-08-10
分类号G01N33/536;
国家 RU
入库时间 2022-08-22 02:45:04

相似文献

专利
外文文献